A carregar...

Prognostic and Predictive Value of the 21-Gene Recurrence Score Assay in a Randomized Trial of Chemotherapy for Postmenopausal, Node-Positive, Estrogen Receptor-Positive Breast Cancer

BACKGROUND: The 21-gene Recurrence Score assay (RS) is prognostic for women with node-negative, estrogen receptor (ER)-positive breast cancer (BC) treated with tamoxifen. A low RS predicts little benefit of chemotherapy. For node-positive BC, we investigated whether RS was prognostic in women treate...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Albain, Kathy S., Barlow, William E., Shak, Steven, Hortobagyi, Gabriel N., Livingston, Robert B., Yeh, I-Tien, Ravdin, Peter, Bugarini, Roberto, Baehner, Frederick L., Davidson, Nancy E., Sledge, George W., Winer, Eric P., Hudis, Clifford, Ingle, James N., Perez, Edith A., Pritchard, Kathleen I., Shepherd, Lois, Gralow, Julie R., Yoshizawa, Carl, Allred, D. Craig, Osborne, C. Kent, Hayes, Daniel F.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3058239/
https://ncbi.nlm.nih.gov/pubmed/20005174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(09)70314-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!